Mulmit

GeoVax Labs, Inc.GeoVax Labs, Inc.

GOVX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-312,489,145-21,639,047-21,464,771
2024-12-313,954,576-25,144,280-24,992,296
2023-12-310-26,742,939-25,966,762
2022-12-3181,526-14,028,564-14,021,125
2021-12-31385,501-18,745,823-18,570,317

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-17SPENCER JOHN N JR6,000
2026-06-17Morgan Jayne6,000
2026-06-17MCNALLY ROBERT T6,000
2026-06-17Lemerond Nicole6,000
2026-06-17Kollintzas Dean G6,000
2026-06-17CHASE RANDAL D6,000
2026-06-17Sharkey John W.VP, Business Development17,600
2026-06-17Reynolds MarkCFO17,600
2026-06-17NEWMAN MARK JChief Scientific Officer17,600
2026-06-17McKee Kelly T. Jr.Chief Medical Officer17,600
2026-06-17DODD DAVID APresident, CEO29,300
2025-10-17SPENCER JOHN N JR10,000

8-K events

FiledItems
2026-09-10Other events · Financial statements and exhibits
2026-08-28Delisting or listing-standard notice · Financial statements and exhibits
2026-08-28Entry into a material agreement · Unregistered sales of equity securities · Financial statements and exhibits
2026-07-27Results of operations · Financial statements and exhibits
2026-07-10Delisting or listing-standard notice
2026-06-17Submission of matters to a vote
2026-05-19Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
2026-05-14Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.